They may not fully replace injectables, especially for patients requiring maximum weight reduction, but they could reshape early intervention, maintenance therapy, emerging market access, and primary care adoption
Tirzepatide is a dual-action GLP-1/GIP agonist that works by mimicking your bodys natural hormones, helping you feel fuller faster and for longer
For hematoxylin-eosin (H&E) staining, paraffin-embedded liver sections were incubated with H&E solutions (Servicebio, Wuhan, China)
Wegovy shows promise for weight loss, but it can have side effects like nausea and diarrhea
Among CKD causes, type 2 diabetes mellitus is notably the only condition demonstrating a significant increase in age-standardized DALY rates between 1990 and 2017, accounting for one-third of CKD-attributable DALYs [2]
I think you always want to go through the risks and benefits of the medication to make sure it is the right choice for the right patient with the right long-term plan